Johnson & Johnson
LSE:0R34
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
LSE:0R34
|
US |
|
T
|
Toppan Inc
DUS:TPX
|
JP |
|
Pioneer Credit Ltd
OTC:PNCRF
|
AU |
|
M
|
McDonald's Corp
DUS:MDO
|
US |
|
C
|
China Longyuan Power Group Corp Ltd
XMUN:6WX
|
CN |
|
BASF SE
SIX:BAS
|
DE |
|
Central Pattana PCL
OTC:CPPBY
|
TH |
|
Codan Ltd
ASX:CDA
|
AU |
|
Prescient Therapeutics Ltd
F:UDD
|
AU |
Intrinsic Value
Is 0R34 undervalued or overvalued?
See the intrinsic value estimate for 
Johnson & Johnson and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Johnson & Johnson Does
Johnson & Johnson is a healthcare company that sells prescription medicines and medical devices. Its drug business focuses on treatments in areas such as immunology, oncology, neuroscience, and infectious disease, while its medical technology business sells products used in surgery, orthopedics, vision care, and other hospital and clinic settings. It no longer includes the consumer health brands that were separated into Kenvue.
- Headquarters
- United States of America US
- Employees
- 138 200
- IPO date
- Sep 25, 1944
Johnson & Johnson has a wide economic moat
Patents and exclusive drug rights prevent rivals from copying important treatments, while hospitals’ investment in specialized equipment and staff training makes changing suppliers costly. Johnson & Johnson combines these protections across medicines and medical devices rather than depending on a single product.
Read the full moat analysis
Revenue & Expenses Breakdown
Johnson & Johnson
Earnings Waterfall
Johnson & Johnson
The intrinsic value for Johnson & Johnson (0R34) under the Base Case is hidden USD.
Compared with the current market price of 154.6 USD, the stock appears hidden.